Canada Spends Logo

Explore our Budget 2026 analysis

Grant: HostSeq Fellowship

University of Calgary

$59,060.00

Solving the genomics of unsolved rare life-threatening COVID-19 using genome sequencing

FY 2022-23

Summary
COVID-19, caused by the SARS-CoV-2 virus, has been declared a pandemic and is one of the most urgent global health crises. The phenotypes of COVID-19 are highly heterogeneous, and a major challenge is the early recognition of severe COVID-19 to support early clinical intervention and targeted therapy. Certain individuals may have a higher risk of severe disease, for example, people with pre-existing respiratory, cardiac, or immune disorders. However, in some rare cases, severe disease occurs in young individuals without any risk factors and is unexplained. We hypothesize that severe illness with COVID-19 in people who do not otherwise have pre-existing risk factors is attributable to monogenic causes in some cases. We have an opportunity to study this in participants recruited to the Alberta Host Genetic Susceptibility project (led by Pfeffer lab) within Hostseq, which focused on younger patients who required hospitalization and did not have pre-existing comorbidities. We will apply cutting-edge genome sequencing (GS) analytical approaches developed by Tarailo-Graovac lab with correlation to comprehensive clinical data. We have successfully applied GS methods to unravel the complex genetic mechanisms underlying rare undiagnosed diseases by identification of previously missed variants of interest. I will work with genomes of the rare severe patients with COVID-19 using the "three stages" and "two levels" strategy to identify causative genes and complex genetic scenarios in independent cohorts. We will apply the background variant information from the Hostseq database to help narrow down the candidates. As such, this work has the potential to build a diagnostic workflow for rare, life-threatening COVID-19 patients and provide clues for identifying individuals predisposed to severe COVID-19 outcomes.
Program
HostSeq Fellowship
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
467728
Name
Shu Li
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Partnername
CGEn (Canada)
Instname2
Genetics
Theme2
Biomedical
Prcname2
CGEn HostSeq/CIHR Joint Postdoctoral Fellowship Program
Projecttitle
Solving the genomics of unsolved rare life-threatening COVID-19 using genome sequencing
Programtype2
Fellowship Programs
Orgnameinp2
University of Calgary
Cihramount2
$59,060
Cihrequipment2
$0
Programname2
HostSeq Fellowship
Keyworddelim
Bioinformatic Analysis; Complex Variants; Covid-19; Genetics; Genome Sequencing; Life-Threatening; Pandemic; Rare Disease
Abstract
COVID-19, caused by the SARS-CoV-2 virus, has been declared a pandemic and is one of the most urgent global health crises. The phenotypes of COVID-19 are highly heterogeneous, and a major challenge is the early recognition of severe COVID-19 to support early clinical intervention and targeted therapy. Certain individuals may have a higher risk of severe disease, for example, people with pre-existing respiratory, cardiac, or immune disorders. However, in some rare cases, severe disease occurs in young individuals without any risk factors and is unexplained. We hypothesize that severe illness with COVID-19 in people who do not otherwise have pre-existing risk factors is attributable to monogenic causes in some cases. We have an opportunity to study this in participants recruited to the Alberta Host Genetic Susceptibility project (led by Pfeffer lab) within Hostseq, which focused on younger patients who required hospitalization and did not have pre-existing comorbidities. We will apply cutting-edge genome sequencing (GS) analytical approaches developed by Tarailo-Graovac lab with correlation to comprehensive clinical data. We have successfully applied GS methods to unravel the complex genetic mechanisms underlying rare undiagnosed diseases by identification of previously missed variants of interest. I will work with genomes of the rare severe patients with COVID-19 using the "three stages" and "two levels" strategy to identify causative genes and complex genetic scenarios in independent cohorts. We will apply the background variant information from the Hostseq database to help narrow down the candidates. As such, this work has the potential to build a diagnostic workflow for rare, life-threatening COVID-19 patients and provide clues for identifying individuals predisposed to severe COVID-19 outcomes.
Competitiondate
202207
Approvedterm2
1 yr 0 mth
Pinamesdelim
Shu, Li
Approvedterm
1 an 0 mois
Cihrcontribution2
Institute of Genetics~ $59,060~ $0~